IP Verse

Protein Based Excipient For Active Pharmaceutical Ingredients - EP3448435

The patent EP3448435 was granted to Dispersome on Jun 1, 2022. The application was originally filed on Apr 28, 2017 under application number EP17722708A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3448435

DISPERSOME
Application Number
EP17722708A
Filing Date
Apr 28, 2017
Status
Granted And Under Opposition
Apr 29, 2022
Grant Date
Jun 1, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

EVONIK OPERATIONSFeb 28, 2023-ADMISSIBLE
GELITAFeb 28, 2023HOEGERADMISSIBLE

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONUS2004175328
EXAMINATIONUS2005031692
EXAMINATIONWO2009063367
INTERNATIONAL-SEARCH-REPORTUS5384129
INTERNATIONAL-SEARCH-REPORTWO2016041995
INTERNATIONAL-SEARCH-REPORTWO9814174
OPPOSITIONJPH11189548
OPPOSITIONUS2005031692
OPPOSITIONUS2012225118
OPPOSITIONUS5384129
OPPOSITIONUS5902606
OPPOSITIONWO0162226
OPPOSITIONWO2009063367
OPPOSITIONWO2011031462
OPPOSITIONWO2016041995
OPPOSITIONWO9814174
OTHERUS2004175328
OTHERUS2005031692
OTHERWO2009063367

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Jones Georgi et al, "Notices, DEPARTMENT OF HEALTH AND HUMAN SERVICES", Federal Register, (19971224), vol. 62, no. 247, pages 67377 - 67388, XP093033569-
OPPOSITION- Singh U V, Udupa N, "Influence of egg albumin of dissolution of Methotrexate", Indian Journal of Pharmaceutical Sciences, (19970101), pages 333 - 335, XP093033402-
OPPOSITION- Suzuki Sachiko et al, "Application of Solid Dispersion t Enhance Dissolution Properties of Mefenamic Acid with Casein", Jpn.J. Hosp. Pharm., (19910423), vol. 17, no. 5, pages 298 - 305, XP093033397-
OPPOSITION- Zhang Hui, Huo Meirong, Zhou Jianping, Zhang Zhixiang, "Preparation and characterization of itraconazole albumin nanosuspension", Journal of China Pharmaceutical University, (20080101), vol. 39, no. 6, pages 510 - 514, XP093033528-
OPPOSITION- Paudel Amrit et al, "Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: Formulation and process considerations", International Journal of Pharmaceutics, ELSEVIER, NL, NL , (20120720), vol. 453, no. 1, doi:10.1016/j.ijpharm.2012.07.015, ISSN 0378-5173, pages 253 - 284, XP028675204
OPPOSITION- Vialpando Monica et al, "Evaluation of Three Amorphous Drug Delivery Technologies to Improve the Oral Absorption of Flubendazole", Journal of Pharmaceutical Sciences, American Chemical Society and American Pharmaceutical Association, US, US , (20160901), vol. 105, no. 9, doi:10.1016/j.xphs.2016.03.003, ISSN 0022-3549, pages 2782 - 2793, XP093033534
OPPOSITION- Jachowicz Renata, Nürnberg Eberhard, "Enhanced release of oxazepam from tablets containing solid dispersions", International Journal of Pharmaceutics, ELSEVIER, NL, NL , (19971201), vol. 159, no. 2, doi:10.1016/S0378-5173(97)00279-2, ISSN 0378-5173, pages 149 - 158, XP093031765
OPPOSITION- Santosh Bhende; Namdeo Jadhav, "Moringa Coagulant as a Stabilizer for Amorphous Solids: Part I", AAPS PHARMSCITECH, Springer New York LLC, US, US , (20120223), vol. 13, no. 2, doi:10.1208/s12249-012-9755-x, ISSN 1530-9932, pages 400 - 410, XP035064310
OPPOSITION- Kim Min-Soo, Baek In-Hwan, Ha Eun-Sol, Yoo Jin-Wook, Jung Yunjin, "Design of a gelatin microparticle-containing self-microemulsifying formulation for enhanced oral bioavailability of dutasteride", Drug Design, Development and Therapy, doi:10.2147/DDDT.S86458, pages 3231 - 3238, XP093033536

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents